Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report) shares passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.01 and traded as low as $0.0078. Evofem Biosciences shares last traded at $0.0085, with a volume of 317,881 shares traded.
Evofem Biosciences Price Performance
The company has a market capitalization of $1.13 million, a P/E ratio of -0.01 and a beta of -1.33. The business’s 50-day moving average price is $0.01 and its two-hundred day moving average price is $0.01.
Evofem Biosciences Company Profile
Evofem Biosciences is a clinical‐stage biotechnology company based in San Diego, California, specializing in women’s sexual and reproductive health. Founded in 2013 as a spin-out of the Scripps Research Institute, the company is focused on developing non-hormonal, on-demand products that address unmet needs in contraception and the prevention of sexually transmitted infections.
The company’s lead commercial product, Phexxi, is an FDA-approved, non-hormonal vaginal gel that maintains the vagina’s natural pH to reduce the risk of unintended pregnancy.
Recommended Stories
- Five stocks we like better than Evofem Biosciences
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
